The Emerging Role of Liquid Biopsies in Lymphoproliferative Disorders

被引:5
作者
Crombie, Jennifer [1 ]
Armand, Philippe [1 ]
机构
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
关键词
Liquid biopsy; Cell-free DNA; Lymphoma; Lymphoproliferative disorders; Minimal residual disease; MANTLE-CELL LYMPHOMA; MINIMAL RESIDUAL DISEASE; CIRCULATING TUMOR DNA; PROGRESSION-FREE SURVIVAL; PREVIOUSLY UNTREATED PATIENTS; POSITRON-EMISSION-TOMOGRAPHY; STAGE HODGKINS LYMPHOMA; FOLLICULAR LYMPHOMA; PROGNOSTIC VALUE; FOLLOW-UP;
D O I
10.1007/s11899-019-0493-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose of the ReviewLymphomas represent clinically and molecularly heterogeneous diseases with variable presentations, treatment algorithms, and outcomes. As treatment options continue to expand, more sophisticated prognostic and predictive biomarkers are needed to guide personalized treatment approaches.Recent FindingsLiquid biopsies, in which the sequencing of circulating tumor DNA (ctDNA) in peripheral blood serves as a surrogate for a tumor biopsy, are now being studied across cancer subtypes, including in lymphoid malignancies. Recent studies have demonstrated the potential of these techniques to improve prognostication and guide individualized treatment strategies, providing a significant advance in the field of precision medicine.SummaryIn this review, we describe the sequencing platforms currently available for analysis of ctDNA in lymphoma and their potential applications in clinical practice, which seem poised to refine treatment paradigms across lymphoma subtypes.
引用
收藏
页码:11 / 21
页数:11
相关论文
共 76 条
[41]   Rapid clearance of fetal DNA from maternal plasma [J].
Lo, YMD ;
Zhang, J ;
Leung, TN ;
Lau, TK ;
Chang, AMZ ;
Hjelm, NM .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 64 (01) :218-224
[42]   Update on mantle cell lymphoma [J].
Maddocks, Kami .
BLOOD, 2018, 132 (16) :1647-1656
[43]   Outcome of Deferred Initial Therapy in Mantle-Cell Lymphoma [J].
Martin, Peter ;
Chadburn, Amy ;
Christos, Paul ;
Weil, Karen ;
Furman, Richard R. ;
Ruan, Jia ;
Elstrom, Rebecca ;
Niesvizky, Ruben ;
Ely, Scott ;
DiLiberto, Maurizio ;
Melnick, Ari ;
Knowles, Daniel M. ;
Chen-Kiang, Selina ;
Coleman, Morton ;
Leonard, John P. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (08) :1209-1213
[44]  
Melani C, 2016, ONCOLOGY-NY, V30, P731
[45]   Risk-Adapted Dose-Dense Immunochemotherapy Determined by Interim FDG-PET in Advanced-Stage Diffuse Large B-Cell Lymphoma [J].
Moskowitz, Craig H. ;
Schoeder, Heiko ;
Teruya-Feldstein, Julie ;
Sima, Camelia ;
Iasonos, Alexia ;
Portlock, Carol S. ;
Straus, David ;
Noy, Ariela ;
Palomba, Maria L. ;
O'Connor, Owen A. ;
Horwitz, Steven ;
Weaver, Sarah A. ;
Meikle, Jessica L. ;
Filippa, Daniel A. ;
Caravelli, James F. ;
Hamlin, Paul A. ;
Zelenetz, Andrew D. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (11) :1896-1903
[46]   Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma [J].
Okosun, Jessica ;
Boedoer, Csaba ;
Wang, Jun ;
Araf, Shamzah ;
Yang, Cheng-Yuan ;
Pan, Chenyi ;
Boller, Soeren ;
Cittaro, Davide ;
Bozek, Monika ;
Iqbal, Sameena ;
Matthews, Janet ;
Wrench, David ;
Marzec, Jacek ;
Tawana, Kiran ;
Popov, Nikolay ;
O'Riain, Ciaran ;
O'Shea, Derville ;
Carlotti, Emanuela ;
Davies, Andrew ;
Lawrie, Charles H. ;
Matolcsy, Andras ;
Calaminici, Maria ;
Norton, Andrew ;
Byers, Richard J. ;
Mein, Charles ;
Stupka, Elia ;
Lister, T. Andrew ;
Lenz, Georg ;
Montoto, Silvia ;
Gribben, John G. ;
Fan, Yuhong ;
Grosschedl, Rudolf ;
Chelala, Claude ;
Fitzgibbon, Jude .
NATURE GENETICS, 2014, 46 (02) :176-+
[47]   Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry [J].
Pastore, Alessandro ;
Jurinovic, Vindi ;
Kridel, Robert ;
Hoster, Eva ;
Staiger, Annette M. ;
Szczepanowski, Monika ;
Pott, Christiane ;
Kopp, Nadja ;
Murakami, Mark ;
Horn, Heike ;
Leich, Ellen ;
Moccia, Alden A. ;
Mottok, Anja ;
Sunkavalli, Ashwini ;
Van Hummelen, Paul ;
Ducar, Matthew ;
Ennishi, Daisuke ;
Shulha, Hennady P. ;
Hother, Christoffer ;
Connors, Joseph M. ;
Sehn, Laurie H. ;
Dreyling, Martin ;
Neuberg, Donna ;
Moeller, Peter ;
Feller, Alfred C. ;
Hansmann, Martin L. ;
Stein, Harald ;
Rosenwald, Andreas ;
Ott, German ;
Klapper, Wolfram ;
Unterhalt, Michael ;
Hiddemann, Wolfgang ;
Gascoyne, Randy D. ;
Weinstock, David M. ;
Weigert, Oliver .
LANCET ONCOLOGY, 2015, 16 (09) :1111-1122
[48]   Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas:: a randomised controlled trial (RICOVER-60) [J].
Pfreundschuh, Michael ;
Schubert, Joerg ;
Ziepert, Marita ;
Schmits, Rudolf ;
Mohren, Martin ;
Lengfelder, Eva ;
Reiser, Marcel ;
Nickenig, Christina ;
Clemens, Michael ;
Peter, Norma ;
Bokemeyer, Carsten ;
Eimermacher, Hartmut ;
Ho, Anthony ;
Hoffmann, Martin ;
Mertelsmann, Roland ;
Truemper, Lorenz ;
Balleisen, Leopold ;
Liersch, Ruediger ;
Metzner, Bernd ;
Hartmann, Frank ;
Glass, Bertram ;
Poeschel, Viola ;
Schmitz, Norbert ;
Ruebe, Christian ;
Feller, Alfred C. ;
Loeffler, Markus .
LANCET ONCOLOGY, 2008, 9 (02) :105-116
[49]  
Pott Christiane, 2013, Methods Mol Biol, V971, P175, DOI 10.1007/978-1-62703-269-8_10
[50]   Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study [J].
Pott, Christiane ;
Hoster, Eva ;
Delfau-Larue, Marie-Helene ;
Beldjord, Kheira ;
Boettcher, Sebastian ;
Asnafi, Vahid ;
Plonquet, Anne ;
Siebert, Reiner ;
Callet-Bauchu, Evelyne ;
Andersen, Niels ;
van Dongen, Jacques J. M. ;
Klapper, Wolfram ;
Berger, Francoise ;
Ribrag, Vincent ;
van Hoof, Achiel L. ;
Trneny, Marek ;
Walewski, Jan ;
Dreger, Peter ;
Unterhalt, Michael ;
Hiddemann, Wolfgang ;
Kneba, Michael ;
Kluin-Nelemans, Hanneke C. ;
Hermine, Olivier ;
Macintyre, Elizabeth ;
Dreyling, Martin .
BLOOD, 2010, 115 (16) :3215-3223